Navigation Links
Bionovo to Present Recent Findings of BZL101, Its Anti-cancer,Agent, at the American Association of Cancer Research

clinical trials by the end of 2007. The company is developing its products in close collaboration with leading U.S. academic research centers, including the University of California, San Francisco, University of Colorado Health Sciences Center and University of California, Berkeley. For further information please visit: http://www.bionovo.com.

Forward-Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.

CONTACT: Jim Stapleton, Chief Financial Officer, +1-510-420-4180,; media, Katherina Audley, +1-415-847-7295,, both of BioNovo jim@bionovo.com Katherina.audley@bionovo.com

Web site:




Page: 1 2 3

Related medicine technology :

1. Bionovos MF101 Shows Positive Safety, Tolerability and Efficacy in Phase 2 Trial
2. The Past, Present and Future of HLA Typing
3. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
4. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
(Date:12/16/2009)... 16 , ... Microplasmin Recruits a Total of Over,640 patients ... ThromboGenics NV (Euronext Brussels: THR), a ... of innovative treatments for eye,disease, vascular disease ... completed,the enrolment of the second Phase III ...
(Date:12/15/2009)... Corporation (Nasdaq: VOLC ), a leading developer ... Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), Forward ... designed to enhance the diagnosis and treatment of ... placement of over 2,500 s5 family consoles worldwide. ... launched in April 2006, with more than 1,000 ...
(Date:12/15/2009)... CITY, Dec. 15 Sonic Innovations, Inc. ... services and solutions, donated $10,000 to its local ... Dec. 14, 2009. ,, Sonic Innovations President Paul ... Feeding America member, the Utah Food Bank, at ... employees also participated in an office food drive ...
Breaking Medicine Technology:ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 2ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 3ThromboGenics Completes Patient Enrolment of Second Phase III Trial of Microplasmin for the Non-Surgical Treatment of Eye Disease 4Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Sonic Innovations, Inc. Donates $10,000 to Feeding America 2Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 50195 1Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 50195 2Aegis Living Was Created To Place People First in Senior and Assisted Living Communities 50195 3Photos 3A Selecciones Readers Digest The American Heart Associations Go Red For Women and Macys Reach Hispanic Women With Message of Heart Health 50191 1Photos 3A Selecciones Readers Digest The American Heart Associations Go Red For Women and Macys Reach Hispanic Women With Message of Heart Health 50191 2Researchers see evidence of memory in the songbird brain 9024 1Researchers see evidence of memory in the songbird brain 9024 2
... July 10, 2007 /CNW/ - Protox,Therapeutics Inc. (TSX-V:PRX) today ... trial evaluating ,PRX302 in patients with localized, recurrent prostate ... is safe and well tolerated and shows promising ... , ,"The completion of ...
... PORTLAND, Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPharma, ... has,completed target patient enrollment and released six-month,follow-up data ... Appraisal.,The trial, currently being held in Germany, was ... drug Resten-MP(TM), when,used in conjunction with the placement ...
Other Medicine Technology:Protox Announces Positive Clinical Data from Prostate Cancer Study 2Protox Announces Positive Clinical Data from Prostate Cancer Study 3Protox Announces Positive Clinical Data from Prostate Cancer Study 4Protox Announces Positive Clinical Data from Prostate Cancer Study 5AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2
(Date:12/16/2009)... Podiatric Medical Association’s Seal of Acceptance , ... ... shoppers continue their search for the perfect gift this season, ... that are considered healthy for the environment. When it comes ... today’s most stylish items are also healthy for feet—making a ...
(Date:12/16/2009)... of products that help survivors of stroke and other forms ... of an interview with the inventors of their brand new ... and Rehab Medicine, vol. 20, issue 20, page 26, 2009; ... ... (PRWEB) December 16, 2009 -- In the publication, entitled ...
(Date:12/16/2009)... are rapidly approaching and what would be the perfect gift to ... of course! Celebrity Beauty Engineer® and Licensed Esthetician Mary Schook introduces ... look and feel their best! , ... (PRWEB) December ... of gift does a person get that special woman who has ...
(Date:12/15/2009)... successfully developed a new electrophoretic method for detecting ... The technique, using SARCOSYL-PAGE, has specifically enhanced ... performance characteristics of SDS-PAGE for detecting other EPOs. ... grant from the World Anti-Doping Agency (WADA), appear ... and Analysis published by Wiley-Blackwell. , MIRCERA ...
(Date:12/15/2009)... Watchdog Calls For Preserving State Authority, Ban on ... ,, WASHINGTON, Dec. 15 Consumer Watchdog ... for those over 55 and the public option ... the group said that the Senate must still ... bill to prevent ceding the entire health care ...
Breaking Medicine News(10 mins):Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 2Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 3Health News:Put Some "Green" Into Gift-Giving With Eco-Friendly Footwear Products 4Health News:New Tailwind Device Improves Arm Function in Stroke Survivors with Paralysis 2Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:Researchers discover novel method for detecting MIRCERA 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5
... Sept. 4 BlueCross BlueShield of South,Carolina plans ... plans and make these available in real time ... Together with ParadigmHealth, a provider and integrator of ... make the new Integrated,Care Management platform available to ...
... Should doctors be,involved in the state-ordered administration of ... Proceedings, three anesthesiologists and a,medical ethicist take an ... and,two editorials., None of these articles debate ... the current position of the,American Medical Association (AMA), ...
... rate when parents took part in therapy , , TUESDAY, Sept. ... in the treatment of teens with bulimia, a new study ... program, the percentage of teens able to abstain from the ... have often been seen as part of the problem, rather ...
... of common allergens, OMAHA, Neb., Sept. 4 Everyday ... bombarded by contaminants and,allergens, such as dust mites, animal dander, ... that any air that gets in --,good or bad -- ... the more important. Try to prevent as many allergens ...
... Endocrinologists (AACE) and Lilly join to, provide patients and physicians with ... ... season arrives, INDIANAPOLIS and JACKSONVILLE, Fla., Sept. 4 With,hurricane ... disasters hitting communities across the United States, the,American Association of Clinical ...
... Services (TCS),(BSE: TCS.BO, NSE: TCS.NS), a leading IT ... of the world,s leading research-focused,healthcare groups in the ... have announced a partnership to,advance Roche,s Global Capacity ... provide services to a number of areas in,Roche,s ...
Other Medicine News:Health News:S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time 2Health News:S.C. BlueCross to Integrate Care Management with Personal Health Record in Real Time 3Health News:Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment 2Health News:Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment 3Health News:Parental Involvement Key to Battling Bulimia 2Health News:Parental Involvement Key to Battling Bulimia 3Health News:Clean to Ease Allergy and Asthma Symptoms 2Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 2Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 3Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 4Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 5Health News:Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions 6Health News:Tata Consultancy Services to Support Roche's Global Capacity Building Initiative 2Health News:Tata Consultancy Services to Support Roche's Global Capacity Building Initiative 3
Bench Top Vertical Airflow Cabinets Production Protection...
... sealed isolation chamber provides a safe, ... sterile pharmaceuticals, in accord with USP-797 ... 100 (ISO 5) cleanliness conditions in ... IV rod and tilt-up front panel ...
... chemical fumes, allowing safe indoor ... filters remove most organic contaminants. ... flow speed = 100 fpm ... air speed monitor, quick-release filter/blower ...
This modular benchtop fume hood ventilates and purifies chemical fumes, allowing safe indoor release of exhaust. Bonded charcoal filters remove most organic contaminants. Options include final HEPA f...
Medicine Products: